webinar register page

Webinar banner
Explaining SLT and the LiGHT Trial
Due to its excellent benefit-to-risk profile, Selective Laser Trabeculoplasty, or SLT, is being offered earlier in the treatment of glaucoma, including as primary therapy. Learn about a recent major study that showed glaucoma patients receiving this simple 5-minute laser procedure did as well or better than those treated with eye drops.

Inder Paul Singh, MD, President of The Eye Centers of Racine & Kenosha, will share his insights about the benefits of SLT for glaucoma, and Gus Gazzard, MD, Director of the Glaucoma Service at Moorfields Eye Hospital, will discuss results from the “Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial,” which aimed to establish whether initial treatment with SLT is superior to initial treatment with topical medication for primary open-angle glaucoma or ocular hypertension. The webinar will be moderated by Thomas M. Brunner, President and CEO of Glaucoma Research Foundation.

Following the presentations, attendees will have an opportunity to submit questions for Dr. Singh and Dr. Gazzard during the live Q&A session.

Sep 27, 2022 11:00 AM in Pacific Time (US and Canada)

* Required information


Thomas M. Brunner
President and CEO @Glaucoma Research Foundation
Tom Brunner joined Glaucoma Research Foundation in 2003 after a successful 30-year career in the ophthalmic laser business. He helped introduce major advances in eye care including laser photocoagulation to prevent vision loss from diabetic retinopathy, laser treatment of secondary cataracts, Tom has helped to more than double revenue and focus on innovative research to understand how glaucoma steals sight and find a cure. He received a “lifetime Achievement” award from the American Society for Laser Medicine and Surgery for his contributions and 25 years of service on their Board of Directors. Tom actively supports development of new products to help those with glaucoma and other eye diseases as an advisor or board member for startup companies in the eye care field. Tom graduated from Lehigh University with a degree in electrical engineering and received an MBA from the University of Delaware.
Gus Gazzard, MD, MBBChir, MA, FRCOphth
Director of Glaucoma Service at Moorfields Eye Hospital, Professor in Ophthalmology, Glaucoma Studies @UCL London
Dr. Gazzard is the Director of Glaucoma Services at Moorfields, Professor of Ophthalmology in Glaucoma Studies at UCL London, a Consultant Ophthalmic Surgeon (Glaucoma and Cataract) and Chief Investigator of the Light Trial of Laser Treatment for Glaucoma. He has a considerable experience in his chosen field, developed through decades of work and research both within the UK and internationally. His primary expertise are cataracts, glaucoma and the medical, laser and surgical treatment of glaucoma. Professor Gazzard is the recipient of the prestigious, competitively awarded “NHS National Silver Merit Award” and is both organizer and lecturer at The Moorfields International Glaucoma Symposium.
Inder Paul Singh, MD
Ophthalmologist President @The Eye Centers if Racine & Kenosha, Ltd.
Dr. I. Paul Singh, a Wisconsin native, is the President of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He was a chief resident and completed his residency at Cook County Hospital Division of Ophthalmology, and his internship at Michael Reese Hospital Department of Medicine, both in Chicago, Illinois. He graduated from Finch University of Health Sciences, The Chicago Medical School in 1999. His undergraduate education was completed at Washington University in St. Louis, with a B.A. in Biology and Psychology. He completed his fellowship in Glaucoma at Duke University in July 2004 before returning to his hometown where he is currently in private practice. Throughout his ophthalmology career, Dr. Singh has been involved with clinical research and has published papers in several ophthalmology journals.